Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors

R. Kefford, H. Arkenau, M. P. Brown, M. Millward, J. R. Infante, G. V. Long, D. Ouellet, M. Curtis, P. F. Lebowitz, G. S. Falchook

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

107 Citations (Web of Science)
Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Volume28
Issue number15
DOIs
Publication statusPublished - 20 May 2010
Externally publishedYes

Cite this